Her primary areas of investigation include Immunology, Chronic lymphocytic leukemia, Internal medicine, Leukemia and Immunophenotyping. The Immunology study combines topics in areas such as Guideline, Haematopoiesis and Virology. The various areas that she examines in her Chronic lymphocytic leukemia study include Cancer research, Stem cell marker, B cell, Loss of heterozygosity and Single-nucleotide polymorphism.
Her research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology. Her Leukemia research incorporates themes from Alemtuzumab and Pentostatin. Estella Matutes has researched Immunophenotyping in several fields, including Lymphoproliferative disorders, Pathology, Clinical value, CD5 and Acute leukemia.
Estella Matutes spends much of her time researching Immunology, Internal medicine, Pathology, Chronic lymphocytic leukemia and Lymphoma. As part of the same scientific family, she usually focuses on Immunology, concentrating on Stem cell marker and intersecting with Cancer research. Her work deals with themes such as Gastroenterology, Surgery and Oncology, which intersect with Internal medicine.
Her studies deal with areas such as Fluorescence in situ hybridization and Splenic marginal zone lymphoma as well as Pathology. Her Chronic lymphocytic leukemia study incorporates themes from Trisomy, Locus, Mutation and B cell. Her Lymphoma research is multidisciplinary, relying on both Serology, Chemotherapy and Splenectomy.
Estella Matutes mostly deals with Immunology, Cancer research, Chronic lymphocytic leukemia, Leukemia and Internal medicine. She combines subjects such as Clinical trial, Disease and Gene expression profiling with her study of Immunology. Her study looks at the relationship between Cancer research and fields such as Hairy cell leukemia, as well as how they intersect with chemical problems.
Her work carried out in the field of Chronic lymphocytic leukemia brings together such families of science as Cancer, Newly diagnosed, Immunoglobulin levels, Pathology and Hypogammaglobulinemia. Her research integrates issues of Mutation, Exome sequencing and Survival analysis in her study of Leukemia. The concepts of her Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Oncology.
Her main research concerns Internal medicine, Leukemia, Chronic lymphocytic leukemia, Immunology and Cancer research. Her research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Survival rate and Surgery. Her Leukemia study combines topics in areas such as Chlorambucil, Cyclophosphamide, Fludarabine, Cancer and Mutation.
The concepts of her Chronic lymphocytic leukemia study are interwoven with issues in Genome-wide association study, Imatinib mesylate, Hematology, Locus and Survival analysis. The various areas that Estella Matutes examines in her Immunology study include Oncology, Germline, Philadelphia chromosome, Genotype and Genetic association. Her Cancer research study incorporates themes from Cladribine, Lymphocytosis, Immunophenotyping, Hairy Cell and Bone marrow.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL).
Bene Mc;Castoldi G;Knapp W;Ludwig Wd.
Leukemia (1995)
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D Catovsky;S Richards;E Matutes;D Oscier.
The Lancet (2007)
Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia.
E Matutes;V Brito-Babapulle;J Swansbury;J Ellis.
Blood (1991)
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
Elisabeth J. Moreau;Estella Matutes;Roger P. A’Hern;Alison M. Morilla.
American Journal of Clinical Pathology (1997)
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
Maria Chiara Di Bernardo;Dalemari Crowther-Swanepoel;Peter Broderick;Emily Webb.
Nature Genetics (2008)
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
Claire E. Dearden;Estella Matutes;Bruno Cazin;Geir E. Tjønnfjord.
Blood (2001)
A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
Jenny Orchard;Richard Garand;Zadie Davis;Gavin Babbage.
Blood (2003)
Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H.
Lia Ginaldi;T Massimo De Martinis;Estella Matutes;Nahla Farahat.
Leukemia Research (1998)
Mutational Status of the TP53 Gene As a Predictor of Response and Survival in Patients With Chronic Lymphocytic Leukemia: Results From the LRF CLL4 Trial
David Gonzalez;Pilar Martinez;Rachel Wade;Sarah Hockley.
Journal of Clinical Oncology (2011)
Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification
Estella Matutes;Winfried F. Pickl;Mars van't Veer;Ricardo Morilla.
Blood (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Institute of Cancer Research
Royal Marsden NHS Foundation Trust
Royal Bournemouth Hospital
University of California, San Diego
New York University
University of Leicester
Institute of Cancer Research
University of Rochester Medical Center
University of Chicago
Instituto de Salud Carlos III
Purdue University West Lafayette
Centre national de la recherche scientifique, CNRS
Albert Einstein College of Medicine
University of California, Santa Barbara
University of Quebec at Montreal
American Museum of Natural History
Colorado State University
Federal University of Sao Paulo
Uniformed Services University of the Health Sciences
Tohoku University
Imperial College London
University of Minnesota
National Aeronautics and Space Administration
Planetary Science Institute
National Oceanography Centre
Toronto Metropolitan University